Noble Capital Markets initiated coverage on Gyre Therapeutics
$GYRE
Biotechnology: Pharmaceutical Preparations
Health Care
Noble Capital Markets initiated coverage of Gyre Therapeutics with a rating of Outperform
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 3/11/2025 | Outperform | Noble Capital Markets |
4 - GYRE THERAPEUTICS, INC. (0001124105) (Issuer)
4 - GYRE THERAPEUTICS, INC. (0001124105) (Issuer)
4 - GYRE THERAPEUTICS, INC. (0001124105) (Issuer)